FGF-23 levels increasing may contribute directly to the transition of AKI to chronicity, through profibrotic effects and effects on renal immune function damage, and LPA plays an important role throughout the process by activating LPA receptor 1 (11, 25, 33, 34). This evidence concerns the gene LPAR1 and acute kidney injury.